EyeC reports growth in key business areas in Q4 2022
The American partner EyeC America contributed to this with an order intake above the €2 million mark
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
financial growth
Eris Lifesciences’s Q2FY23 revenue up 28 per cent YoY
EBITDA at Rs 1,514 million, with 32.9 per cent EBITDA margin; PAT stood at Rs 1,194 million, with 25.9 per cent PAT margin